Effects of bezafibrate therapy on subfractions of plasma low-density lipoprotein and high-density lipoprotein, and on activities of lecithin: cholesterol acyltransferase and cholesteryl ester transfer protein in patients with hyperlipoproteinemia

This publication has 65 references indexed in Scilit:

• Double-blind comparison of bezafibrate versus placebo in male volunteers with hyperlipoproteinemia
  Atherosclerosis, 1992
• Effects of simvastatin, bezafibrate and gemfibrozil on the quantity and composition of plasma lipoproteins
  Atherosclerosis, 1990
• Interruption of long-term lipid-lowering treatment with bezafibrate in hypertriglyceridaemic patients Effects on lipoprotein composition, lipase activities and the plasma lipid fatty acid spectrum
  Atherosclerosis, 1990
• COMPARISON BETWEEN SIMVASTATIN AND BEZAFIBRATE IN EFFECT ON PLASMA LIPOPROTEINS AND APOLIPOPROTEINS IN PRIMARY HYPERCHOLESTEROLAEMIA
  The Lancet, 1988
• High-density lipoprotein subfractions in normolipidemic patients with coronary atherosclerosis.
  Circulation, 1982
• Characterization of human high-density lipoproteins by gradient gel electrophoresis
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1981
• Effects of bezafibrate on the serum lipoprotein lipid and apolipoprotein composition, lipoprotein triglyceride removal capacity and the fatty acid composition of the plasma lipid esters
  Atherosclerosis, 1980
• Lipoprotein substrates of lipoprotein lipase and hepatic triacylglycerol lipase from human post-heparin plasma
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1979
• One-year study of the effect of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinaemia
  Atherosclerosis, 1978
• Dose-response study of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinaemia
  Atherosclerosis, 1978